jueves, 9 de enero de 2020

Combining therapy with recombinant human endostatin and cytotoxic agents for recurrent disseminated glioblastoma: a retrospective study | BMC Cancer | Full Text

Combining therapy with recombinant human endostatin and cytotoxic agents for recurrent disseminated glioblastoma: a retrospective study | BMC Cancer | Full Text

The optimal chemotherapeutics of recurrent disseminated glioblastoma has yet to be determined. We analyzed the efficacy and safety of recombinant human endostatin (rh-ES) combined with temozolomide and irinote...
Authors:Jing-jing Ge, Cheng Li, Shao-pei Qi, Feng-jun Xue, Zhi-meng Gao, Chun-jiang Yu and Jun-ping Zhang
Citation:BMC Cancer 2020 20:24
Content type:Research article
Published on: 

No hay comentarios:

Publicar un comentario